{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T14:04:13Z","timestamp":1722693853077},"reference-count":11,"publisher":"Japanese Society of Internal Medicine","issue":"22","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,11,15]]},"DOI":"10.2169\/internalmedicine.7295-21","type":"journal-article","created":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T22:10:25Z","timestamp":1622239825000},"page":"3621-3624","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy of Lacosamide in a Patient with Refractory Generalized Epilepsy Based on Video Electroencephalography"],"prefix":"10.2169","volume":"60","author":[{"given":"Hidetada","family":"Yamada","sequence":"first","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuichiro","family":"Neshige","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Japan"},{"name":"Epilepsy Center, Hiroshima University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Shishido","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Japan"},{"name":"Department of Neurology, National Hospital Organization Yanai Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Ueno","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Japan"},{"name":"Epilepsy Center, Hiroshima University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Ohshita","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Morino","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirofumi","family":"Maruyama","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences, Japan"},{"name":"Epilepsy Center, Hiroshima University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 58: 512-521, 2017.","DOI":"10.1111\/epi.13709"},{"key":"2","unstructured":"2. Faught E. Treatment of refractory primary generalized epilepsy. Rev Neurol Dis 1 (Suppl 1): S34-S43, 2004."},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51: 1069-1077, 2010.","DOI":"10.1111\/j.1528-1167.2009.02397.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Vossler DG, Knake S, O&apos;Brien TJ, et al. Efficacy and safety of adjunctive lacosamide in the treatment of primary generalised tonic-clonic seizures: a double-blind, randomised, placebo-controlled trial. J Neurol Neurosurg Psychiatry 91: 1067-1075, 2020.","DOI":"10.1136\/jnnp-2020-323524"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Chaves J, Sander JW. Seizure aggravation in idiopathic generalized epilepsies. Epilepsia 46 (Suppl 9): 133-139, 2005.","DOI":"10.1111\/j.1528-1167.2005.00325.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Shih JJ, Whitlock JB, Chimato N, Vargas E, Karceski SC, Frank RD. Epilepsy treatment in adults and adolescents: expert opinion, 2016. Epilepsy Behav 69: 186-222, 2017.","DOI":"10.1016\/j.yebeh.2016.11.018"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Rogawski MA, Tofighy A, White HS, Matagne A, Wolff C. Current understanding of the mechanism of action of the antiepileptic drug lacosamide. Epilepsy Res 110: 189-205, 2015.","DOI":"10.1016\/j.eplepsyres.2014.11.021"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Abarrategui B, Garc\u00eda-Garc\u00eda ME, Toledano R, Parejo-Carbonell B, Gil-Nagel A, Garc\u00eda-Morales I. Lacosamide for refractory generalized tonic-clonic seizures of non-focal origin in clinical practice: a clinical and VEEG study. Epilepsy Behav Case Rep 8: 63-65, 2017.","DOI":"10.1016\/j.ebcr.2017.08.001"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Wechsler RT, Yates SL, Messenheimer J, Leroy R, Beller C, Doty P. Lacosamide for uncontrolled primary generalized tonic-clonic seizures: an open-label pilot study with 59-week extension. Epilepsy Res 130: 13-20, 2017.","DOI":"10.1016\/j.eplepsyres.2016.12.015"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Birnbaum D, Koubeissi M. Unmasking of myoclonus by lacosamide in generalized epilepsy. Epilepsy Behav Case Rep 7: 28-30, 2017.","DOI":"10.1016\/j.ebcr.2016.09.006"},{"key":"11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/epi4.12360","volume":"4","author":"SB Heavin","year":"2019","unstructured":"11. Heavin SB, McCormack M, Wolking S, et al. Genomic and clinical predictors of lacosamide response in refractory epilepsies. Epilepsia Open 4: 563-571, 2019.","journal-title":"Epilepsia Open","ISSN":"http:\/\/id.crossref.org\/issn\/2470-9239","issn-type":"print"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/22\/60_7295-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T04:42:05Z","timestamp":1715143325000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/22\/60_7295-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,15]]},"references-count":11,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7295-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,15]]},"article-number":"7295-21"}}